Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...

A new survey undertaken by the Harris Poll for Johnson & Johnson has shown how standard forms of surgery and treatment for certain bladder cancer patients are causing a major long-term emotional ...

AstraZeneca’s first foray with PD-L1 inhibitor Imfinzi as a treatment for bladder cancer was a flop. After gaining accelerated approval in the indication in 2017, the company grudgingly clawed back ...

May 14 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Thursday that a late-stage trial of Imfinzi, combined with a targeted therapy prior to a ‌surgery, showed significantly improved survival ...

A drug that helps the immune system find cancer cells also helps patients avoid having their bladders surgically removed (cystectomy), a new study shows. The findings apply to serious cases after ...

Share on Pinterest A new urine test may enable more personalized treatment for bladder cancer. Image credit: SolStock/Getty Images A new urine-based test can detect minimal residual bladder cancer ...

Surgery hasn’t always been an option for metastatic bladder cancer (or bladder cancer that’s spread from its original site). But according to limited research, surgical treatments may now help some ...

Bladder cancer is probably a bit further down your list of concerns than other cancers and conditions. Still, knowing the number-one sign of bladder cancer can help you catch it early and get the ...

Neoadjuvant radioimmunotherapy was safe and led to pathologic response in a proportion of higher-risk trial participants with cT3-4 bladder cancer, including 30% who had clinically positive lymph ...

After partnering with Depend last year following his bladder cancer surgery, Colorado head coach Deion Sanders brought his story to life in his first commercial for the company. Sanders starred in ...

Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...